SAVA

Cassava Sciences, Inc. [SAVA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SAVA Stock Summary

Top 10 Correlated Stocks

SAVA


In the News

02:01 04 Feb 2023 SAVA

Cassava Sciences Stock Undervalued with Its $124 Price Target?

Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a clinical-stage biotechnology firm that develops drugs for Alzheimer's disease (AD).

11:37 04 Feb 2023 SAVA

Cassava Sciences' Data Once Again Misunderstood

Cassava Sciences' Simufilam staved off cognitive decline in mild Alzheimer's disease. The market reacted negatively anyway.

02:01 04 Feb 2023 SAVA

Cassava Sciences: Data For Mild Alzheimer's Disease Patients Provides Good Risk/Reward Profile

Cassava Sciences released data for over 200 patients in an open-label trial at 12 months. The mild AD subgroup performed unprecedentedly.

02:47 04 Feb 2023 SAVA

Why Is Cassava Sciences (SAVA) Stock Down 20% Today?

One of the biggest decliners in today's market is Cassava Sciences (NASDAQ: SAVA ). Shares of SAVA stock declined more than 20% at today's trough on the company's announced mid-stage results for its Alzheimer's treatment.

12:10 04 Feb 2023 SAVA

Cassava Plummets As 'Highly Desirable' Alzheimer's Results Don't Cut It With Investors

Cassava disappointed Tuesday with midstage results for its oral Alzheimer's treatment and SAVA stock plummeted by a double-digit percentage. The post Cassava Plummets As 'Highly Desirable' Alzheimer's Results Don't Cut It With Investors appeared first on Investor's Business Daily.

03:39 04 Feb 2023 SAVA

Is a Short Squeeze Coming in Cassava Sciences (SAVA) Stock?

Amid surging interest in a wide swath of meme stocks today, retail investors are once again seeing traction in trading unpopular names. That said, other companies many may not necessarily associate with the meme trade are also surging.

10:48 04 Feb 2023 SAVA

6 Favorite Biotech Bets For 2023

Biotechnology has often been among the most popular sectors in the MoneyShow Top Picks report, our annual survey of the nation's leading newsletter advisors. This year's report is no exception; here's a six-pack of favorite biotech ideas for the coming year.

04:40 04 Feb 2023 SAVA

Why Is Cassava Sciences (SAVA) Stock Up 10% Today?

The completion of part of an important study is pushing Cassava Sciences (NASDAQ: SAVA ) stock up today. This clinical-stage biotech company has been volatile this month but has overall performed well.

02:51 04 Feb 2023 SAVA

Cassava Sciences Stock's Bull Signal Has Never Been Wrong

The shares of Cassava Sciences Inc  (NASDAQ:SAVA) are down 3.5% at $32.17 this afternoon, after the company announced a $50 million registered direct stock offering on Friday.

10:43 04 Feb 2023 SAVA

7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022

High inflation and soaring interest rates have been the main factor behind the double-digit stock downturn so far this year, but alongside these macro factors, many stocks have plunged due to more company-specific issues—for example, corporate scandals. These scandals run the gamut, both in the type of scandal and the severity of the scandal.

SAVA Financial details

Company Rating
Neutral
Market Cap
1.21B
Income
-61.52M
Revenue
0
Book val./share
4.96
Cash/share
4.36
Dividend
-
Dividend %
-
Employees
24
Optionable
No
Shortable
Yes
Earnings
27 Feb 2023
P/E
-20.52
Forward P/E
-
PEG
-0.38
P/S
-
P/B
6.35
P/C
7.09
P/FCF
-13.79
Quick Ratio
21.02
Current Ratio
22.06
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-1.54
EPS next Y
-
EPS next Q
-
EPS this Y
241.67%
EPS next Y
-
EPS next 5Y
216.56%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
15.91%
-
-
-
-
SMA20
-0.72%
SMA50
-19.34%
SMA100
0.03%
Inst Own
100%
Inst Trans
0%
ROA
-30%
ROE
-26%
ROC
-0.32%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
41.74M
Shs Float
37.77M
-
-
-
-
Target Price
-
52W Range
13.84-62.49
52W High
-50.13%
52W Low
+137.85%
RSI
48.79
Rel Volume
0.69
Avg Volume
1.54M
Volume
1.07M
Perf Week
12.48%
Perf Month
-18.05%
Perf Quarter
51.42%
Perf Half Y
67.14%
-
-
-
-
Beta
-0.021625
-
-
Volatility
1.48%, 2.92%
Prev Close
-1.9%
Price
30.92
Change
7.36%

SAVA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
00000
Net income per share
-1.82-0.61-0.27-0.24-0.82
Operating cash flow per share
-1.26-0.45-0.14-0.21-0.77
Free cash flow per share
-1.26-0.45-0.15-0.22-1.33
Cash per share
1.61.851.333.585.92
Book value per share
1.481.841.273.536.44
Tangible book value per share
1.481.841.273.526.44
Share holders equity per share
1.481.841.273.536.44
Interest debt per share
0000.010.01
Market cap
46.94M12.28M139.82M517.4M1.57B
Enterprise value
36.46M-7.52M116.74M424.19M1.33B
P/E ratio
-3.94-1.87-30.19-81.69-48.37
Price to sales ratio
00000
POCF ratio
-5.7-2.58-55.62-96.14-51.87
PFCF ratio
-5.7-2.58-55.22-90.33-29.89
P/B Ratio
4.840.636.335.616.17
PTB ratio
4.840.636.335.616.17
EV to sales
00000
Enterprise value over EBITDA
-3.071.14-23.82-67.2-40.56
EV to operating cash flow
-4.431.58-46.43-78.82-44.15
EV to free cash flow
-4.431.58-46.1-74.06-25.44
Earnings yield
-0.25-0.53-0.03-0.01-0.02
Free cash flow yield
-0.18-0.39-0.02-0.01-0.03
Debt to equity
00000
Debt to assets
0.10.030.060.020.05
Net debt to EBITDA
0.8834.7114.777.1
Current ratio
9.4239.2216.8350.419.51
Interest coverage
00000
Income quality
0.690.730.540.850.93
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
000.010.060.74
Capex to revenue
00000
Capex to depreciation
00-0.31-15.73-41.6
Stock based compensation to revenue
00000
Graham number
7.85.042.764.3910.92
ROIC
-1.23-0.34-0.22-0.07-0.13
Return on tangible assets
-1.1-0.33-0.2-0.07-0.12
Graham Net
1.431.811.253.55.6
Working capital
9.53M19.53M21.96M92.13M231.95M
Tangible asset value
00000
Net current asset value
9.53M19.53M21.96M91.89M231.62M
Invested capital
00000
Average receivables
00000
Average payables
667.5K602.5K682K911K4.02M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-1.23-0.33-0.21-0.07-0.13
Capex per share
000-0.01-0.56

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-09-30
Revenue per share
00000
Net income per share
-0.13-0.24-0.35-0.44-0.51
Operating cash flow per share
-0.13-0.37-0.2-0.59-0.54
Free cash flow per share
-0.13-0.92-0.2-0.6-0.57
Cash per share
6.966.045.845.254.36
Book value per share
6.926.76.355.934.96
Tangible book value per share
6.926.676.355.914.94
Share holders equity per share
6.926.76.355.934.96
Interest debt per share
0.010.010.010.010.03
Market cap
3.41B2.48B1.75B1.48B1.67B
Enterprise value
3.14B2.24B1.51B1.27B1.5B
P/E ratio
-166.52-64.85-30.8-21.17-20.67
Price to sales ratio
00000
POCF ratio
-664.25-168.01-218.64-63.08-77.72
PFCF ratio
-654.95-67.4-215.93-61.96-73.76
P/B Ratio
12.359.276.886.268.43
PTB ratio
12.359.276.886.268.43
EV to sales
00000
Enterprise value over EBITDA
-611.23-234.7-104.75-72.81-71.29
EV to operating cash flow
-610.16-151.67-189.44-54.17-69.62
EV to free cash flow
-601.61-60.84-187.1-53.21-66.08
Earnings yield
00-0.01-0.01-0.01
Free cash flow yield
0-0.010-0.02-0.01
Debt to equity
00000
Debt to assets
0.020.020.050.030.04
Net debt to EBITDA
54.1925.2916.1511.968.29
Current ratio
60.2939.8219.5132.7322.06
Interest coverage
000-574.87-24.31
Income quality
11.540.561.341.06
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
01.490.010.020.05
Capex to revenue
00000
Capex to depreciation
0-103.97-0.32-1.36-3.85
Stock based compensation to revenue
00000
Graham number
4.4767.127.657.51
ROIC
-0.02-0.04-0.06-0.08-0.11
Return on tangible assets
-0.02-0.04-0.05-0.07-0.1
Graham Net
6.845.885.525.074.15
Working capital
274.92M245.59M231.95M215.41M174.96M
Tangible asset value
0266.36M0236.15M197.98M
Net current asset value
274.73M245.23M231.62M215.1M174.71M
Invested capital
00000
Average receivables
00000
Average payables
2.62M2.84M5.23M3.33M3.43M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.02-0.04-0.06-0.07-0.1
Capex per share
0-0.550-0.01-0.03

SAVA Frequently Asked Questions

What is Cassava Sciences, Inc. stock symbol ?

Cassava Sciences, Inc. is a US stock , located in Austin of Tx and trading under the symbol SAVA

What is Cassava Sciences, Inc. stock quote today ?

Cassava Sciences, Inc. stock price is $30.92 today.

Is Cassava Sciences, Inc. stock public?

Yes, Cassava Sciences, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap